Frailty Among Alzheimer’s Disease Patients
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
12
Page:
507-511
Author(s):
Giacomo Koch, Lorena Belli, Temistocle Lo Giudice, Francesco Di Lorenzo, Giulia Maria Sancesario, Roberto Sorge, Sergio Bernardini and Alessandro Martorana
Curcumin, an Active Constiuent of the Ancient Medicinal Herb Curcuma longa L.: Some Uses and the Establishment and Biological Basis of Medical Efficacy
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
12
Page:
487-497
Author(s):
Jeffrey M. Witkin and Xia Li
(Commentary [Research Highlights] A Toll Road to Alzheimer Disease?)
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
12
Page:
445-446
Author(s):
Stephen D. Skaper
The Multifunctional Anti-inflammatory Drugs Used in the Therapy of Alzheimer’s Disease
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
2583-2588
Author(s):
S. Shi, Z. Wang and Z. Qiao
Plasma Proteins Interaction with Curcumin Nanoparticles: Implications in Cancer Therapeutics
Journal:
Current Drug Metabolism
Volume:
14
Page:
504-515
Author(s):
Murali M. Yallapu, Mara C. Ebeling, Meena Jaggi and Subhash C. Chauhan
Biphasic Mechanisms of Neurovascular Unit Injury and Protection in CNS Diseases
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
12
Page:
302-315
Author(s):
Takakuni Maki, Kazuhide Hayakawa, Loc-Duyen D. Pham, Changhong Xing, Eng H. Lo and Ken Arai
Sirtuins as Possible Targets in Neurodegenerative Diseases
Journal:
Current Drug Targets
Volume:
14
Page:
644-647
Author(s):
Gizem Donmez
Patent Selections
Journal:
Recent Patents on Biomarkers
Volume:
3
Page:
153-156
Author(s):
Effects of Memantine on Event-Related Potentials in Alzheimer’s Disease Under Donepezil Treatment
Journal:
Neuroscience and Biomedical Engineering (Discontinued)
Volume:
1
Page:
34-39
Author(s):
Masatsugu Takano, Yuka Watanabe, Yuya Hoshino, Naoki Izawa, Toshiyuki Kawakami, Hideaki Tanaka and Koichi Hirata
Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
12
Page:
117-128
Author(s):
Qian-sheng Yu, Marcella Reale, Mohammad A. Kamal, Harold W. Holloway, Weiming Luo, Kumar Sambamurti, Balmiki Ray, Debomoy K. Lahiri, Jack T. Rogers and Nigel H. Greig